PTGS2 and cholangiocarcinoma: In cholangiocarcinoma, 22-hydroxycholesterol (22-HC), which is the metabolite of pregnenolone biosynthesis, induces p38-dependent overexpression of the inflammatory protein, cyclooxygenase-2 (COX-2) [34].